LCN2 and pancreatic neoplasm: We also analysed the ability of the serum NGAL assay to distinguish pancreatic cancer from non-cancer cases by fitting the data to a simple logistic regression model where samples were categorised as ‘cancer’ or ‘no-cancer’, and mean NGAL was used as the predictor.